Tender Details

Country: USA
Summary: Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
UST Ref No: 111672898
Deadline: 11 Sep 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: PAR-25-028
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
This Notice Of Funding Opportunity (Nofo) Supports Applications To Develop And Implement Investigator-Initiated Single Site Clinical Trials Including Efficacy, Comparative Effectiveness, Pragmatic And/Or Implementation Research Clinical Trials. These Trials May Include Ones That Test Different Therapeutic, Behavioral, And/Or Prevention Strategies. Trials For Which This Nofo Applies Must Be Relevant To The Research Mission Of The Nhlbi And Meet The Nih Definition Of A Clinical Trial (See Not-Od-15-015). For Additional Information About The Mission, Strategic Vision, And Research Priorities Of The Nhlbi, Applicants Are Encouraged To Consult The Nhlbi Website. This Nofo Will Utilize A Bi-Phasic, Milestone-Driven Mechanism Of Award. The Objective Of The Application Is To Present The Scientific Rationale For The Clinical Trial And A Comprehensive Scientific And Operational Plan That Describes It. The Application Should Address Project Management, Subject Recruitment And Retention, Performance Milestones, Scientific Conduct Of The Trial, And Dissemination Of Results. The Multiple Pd/Pi Model Is Strongly Encouraged But Not Required. Applicants Are Encouraged To Include A Pd/Pi With Expertise In Biostatistics, Clinical Trial Design, And Coordination.
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) - USA Tender

The NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required). This tender is published on USARFP under UST Ref No: 111672898 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-11.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.